Jazz Pharmaceuticals PLC
SWB:J7Z
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
Jazz Pharmaceuticals PLC
SWB:J7Z
|
IE |
|
P
|
PUC Bhd
KLSE:PUC
|
MY |
|
A
|
Argenta Silver Corp
OTC:AGAGF
|
CA |
|
Teijin Ltd
TSE:3401
|
JP |
|
Cobram Estate Olives Ltd
OTC:CBOAF
|
AU |
|
Adi Sarana Armada Tbk PT
IDX:ASSA
|
ID |
Wall St Price Targets
J7Z Price Targets Summary
Jazz Pharmaceuticals PLC
According to Wall Street analysts, the average 1-year price target for J7Z is 224.71 EUR with a low forecast of 173.82 EUR and a high forecast of 279.56 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is J7Z's stock price target?
Price Target
224.71
EUR
According to Wall Street analysts, the average 1-year price target for J7Z is 224.71 EUR with a low forecast of 173.82 EUR and a high forecast of 279.56 EUR.
What is the Revenue forecast for Jazz Pharmaceuticals PLC?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 8%.
What is the Gross Profit forecast for Jazz Pharmaceuticals PLC?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 3 years is 10%.
What is the Operating Income forecast for Jazz Pharmaceuticals PLC?
Projected CAGR
69%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 3 years is 69%.
